This site is intended for healthcare professionals only
LoginRegister
No More Online Ads for Prescription Drugs? Govt Proposes Ban on Schedule G, H, H1 and X MedicinesE-Pharmacy Threat Growing Unchecked: AIOCD Flags Regulatory Failure, Calls for Urgent CDSCO Action
Cybercriminals Trick Dr Reddys Finance Team, Divert Rs 2.16 Crore PaymentDr Reddys Labs invests Rs 565 crore in Russian subsidiary
Senores Pharma arm facility gets 3 USFDA observationsSenores Pharma arm facility gets 3 USFDA observations
Lupin, Sun Pharma and 1 other recall products in USLupin, Sun Pharma and 1 other recall products in US
Inside Coldrif Scandal: Tamil Nadu Plant Used Paint-Grade Chemicals, Violated 300+ Drug NormsOdisha: Huge cache of banned cough syrups seized, 3 arrested
Andhra Pradesh allotts 531.77 acres of land to Laurus LabsAndhra Pradesh allots 531.77 acres of land to Laurus Labs
Roche gets negative EMA Committee opinion on Elevidys CMARoche gets negative EMA Committee opinion on Elevidys CMA for 3-7 year olds with Duchenne muscular...
Zydus gets nod from China NMPA for Major Depressive Disorder drug Venlafaxine ERExpert Committee Clears Ravenbhel to Begin Resmetirom Phase 3 Trial, Asks for BE Data First
Alexion, AstraZeneca Rare Disease Koselugo gets USFDA nod for neurofibromatosis type 1Menopause relief drug: USFDA extends review period for Bayer Elinzanetant
Phase III data for Gazyva/Gazyvaro show significant reduction in disease activity for systemic lupus erythematosus: RocheRoche receives CE Mark for minimally invasive blood test to help rule out Alzheimer's disease
Troikaas Fast-Acting Paracetamol Shot Hits Regulatory Hurdle, CDSCO Panel Seeks More DataTroikaa's Fast-Acting Paracetamol Shot Hits Regulatory Hurdle, CDSCO Panel Seeks More Data
Sanofi Sarclisa approved in EUSanofi Sarclisa approved in EU for transplant-eligible newly diagnosed multiple myeloma
X